Similar articles

• Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab.

  Tarkiainen M, Tynjälä P, Vähäsalo P, Lahdenne P. Tarkiainen M, et al. Scand J Rheumatol. 2011 Mar;40(2):150-2. doi: 10.3109/03009742.2010.499878. Epub 2010 Sep 26. Scand J Rheumatol. 2011. PMID: 20868307 No abstract available.
• Switching tumor necrosis factor alpha inhibitors in HLA-B27-associated severe heel enthesitis.

  Olivieri I, Scarano E, Padula A, D'angelo S, Cantini F. Olivieri I, et al. Arthritis Rheum. 2007 Dec 15;57(8):1572-4. doi: 10.1002/art.23096. Arthritis Rheum. 2007. PMID: 18050233 No abstract available.
• Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.

  Koumakis E, Wipff J, Avouac J, Kahan A, Allanore Y. Koumakis E, et al. J Rheumatol. 2009 Sep;36(9):2125-6. doi: 10.3899/jrheum.090160. J Rheumatol. 2009. PMID: 19738227 No abstract available.
• [Anti-TNF alfa therapy in ankylosing spondylitis].

  Cravo AR, Tavares V, Da Silva JC. Cravo AR, et al. Acta Med Port. 2006 Mar-Apr;19(2):141-50. Epub 2006 Aug 18. Acta Med Port. 2006. PMID: 17187716 Review. Portuguese.
• Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

  Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A, Ohno S, Pipitone N, Schirmer M, Stanford M, Wechsler B, Zouboulis C, Kaklamanis P, Yazici H. Sfikakis PP, et al. Rheumatology (Oxford). 2007 May;46(5):736-41. doi: 10.1093/rheumatology/kem034. Epub 2007 Apr 2. Rheumatology (Oxford). 2007. PMID: 17403712 Review. No abstract available.